BMC Cancer Q2
Unclaimed
BioMed Central Ltd.
United Kingdom
BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 139. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1.134 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1.134.
BMC Cancer focuses its scope in these topics and keywords: cancer, breast, patients, cell, expression, ovarian, study, human, therapy, lung, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Price
2390 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1.134
SJR Impact factor139
H Index1325
Total Docs (Last Year)3740
Total Docs (3 years)51498
Total Refs17667
Total Cites (3 years)3739
Citable Docs (3 years)4.42
Cites/Doc (2 years)38.87
Ref/DocOther journals with similar parameters
Human Gene Therapy Q2
Heredity Q2
Genetic Epidemiology Q2
Mammalian Genome Q2
Genes and Cancer Q2
Compare this journals
Comments